NCT01274676

Brief Summary

Stenting is an alternative to traditional surgery in the treatment of carotid stenosis.The intra and/or postprocedural cerebral embolization remains the most frequent complication. Thanks to the systematic use of cerebral protection systems, these complications have reduced.A debate concerning which cerebral protective device should be more effective is still ongoing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2009

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2010

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

January 10, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 11, 2011

Completed
Last Updated

January 11, 2011

Status Verified

September 1, 2009

Enrollment Period

1 year

First QC Date

January 10, 2011

Last Update Submit

January 10, 2011

Conditions

Keywords

stentingcarotid plaquestenosisangioplasty

Outcome Measures

Primary Outcomes (1)

  • number of Microembolization signals (MES) detected with transcranal doppler

    6 different phases of carotid stenting (lesion wiring; predilation; stent crossing of the lesion; stent deployment; stent post dilation; device tetruieval/deflation

Secondary Outcomes (1)

  • Clinical success

    In hospital and 30 days

Study Arms (2)

carotid stenting with MOMA

ACTIVE COMPARATOR
Device: carotid stenting with MOMA

Carotid stenting with filter wire EZ

ACTIVE COMPARATOR
Device: Carotid stenting with filter wire EZ

Interventions

The MOMA system is an endovascular catheter for proximal protection during carotid stenting. The system allows a concomitant balloon occlusion of both external and common carotid arteries leading to blood flow reversal within the internal carotid artery.

Also known as: MOMA device (INVATEC RONCADELLE, BRESCIA - ITALY)
carotid stenting with MOMA

The filter wire EZ a distal protection system that is placed in he distal internal carotid artery before carotid stenting. The filter should entrap almost all the debries that are generated during endovascular procedure. At the end of the procedure the filter is retrieved throught a dedicated retrieval catheter.

Also known as: Filterwire EZ - Boston Scientific
Carotid stenting with filter wire EZ

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with monolateral, significant, soft carotid stenosis

You may not qualify if:

  • patients with controlateral carotid occlusion
  • patients with critic stenosis of the external carotid

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Cardiologico Monzino, IRCCS

Milan, 20138, Italy

Location

Related Publications (1)

  • Montorsi P, Caputi L, Galli S, Ciceri E, Ballerini G, Agrifoglio M, Ravagnani P, Trabattoni D, Pontone G, Fabbiocchi F, Loaldi A, Parati E, Andreini D, Veglia F, Bartorelli AL. Microembolization during carotid artery stenting in patients with high-risk, lipid-rich plaque. A randomized trial of proximal versus distal cerebral protection. J Am Coll Cardiol. 2011 Oct 11;58(16):1656-63. doi: 10.1016/j.jacc.2011.07.015.

MeSH Terms

Conditions

Carotid StenosisConstriction, Pathologic

Condition Hierarchy (Ancestors)

Carotid Artery DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Piero Montorsi, MD

    Centro Cardiologico Monzino, IRCCS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 10, 2011

First Posted

January 11, 2011

Study Start

February 1, 2009

Primary Completion

February 1, 2010

Study Completion

February 1, 2010

Last Updated

January 11, 2011

Record last verified: 2009-09

Locations